No Do-Overs: Voluntary Dismissal Does Not Reset Deadline for Stay
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Jeremiah S. Helm, Ph.D.
ASCENDIS PHARMA A/S v. BIOMARIN PHARMACEUTICAL INC.
Before Lourie, Chen, and Stoll. Appeal from the United States District Court for the Northern District of California.
Summary: A respondent in an ITC proceeding may not seek a mandatory stay of their refiled declaratory judgment action in a district court action involving the same parties after they had previously filed a declaratory judgment action and failed to meet the deadline to seek a stay under 28 U.S.C. § 1659(a)(2).
BioMarin Pharmaceutical Inc. brought an ITC action against Ascendis accusing certain drug products of patent infringement. Ascendis filed for declaratory judgment of non-infringement in district court. After waiting more than 30 days, Ascendis filed a notice of voluntary dismissal without prejudice. Ascendis explained that it intended to refile its complaint and seek a mandatory stay under 28 U.S.C. § 1659(a)(2). Ascendis then filed a new, nearly identical, declaratory judgment complaint and soon thereafter filed for a mandatory stay. BioMarin opposed the stay as untimely. The district court entered a temporary stay and denied Ascendis’s request for the mandatory stay as moot. Ascendis appealed.
The Federal Circuit affirmed the denial of the mandatory stay, though it disagreed that the temporary stay mooted Ascendis’s request. The court explained that a request for a mandatory stay under 28 U.S.C. § 1659(a)(2) must be made within 30 days after a district court action is filed. Ascendis did not request a mandatory stay within 30 days of its initially filed declaratory judgment action and instead dismissed its complaint with the goal of resetting the deadline. Applying common-law principles and analyzing the statutory text and history, the Federal Circuit explained that a voluntary dismissal cannot be used for the purpose of circumventing the statute’s explicit requirement. Therefore, the court held Ascendis’s request for a mandatory stay under 28 U.S.C. § 1659(a)(2) was untimely.
Co-Author: Saba Zamani (NY State Bar Pending)
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…